Skip to main content
Livermore
Livermore
ZHEN

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
2,903
Value
$1.44M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,903$1.44M<0.1%−109−3.6%ReducedHolders
Q1 20263,012$1.34M<0.1%−215−6.7%ReducedHolders
Q4 20253,227$1.46M0.1%+12+0.4%AddedHolders
Q3 20253,215$1.26M<0.1%−69−2.1%ReducedHolders
Q2 20253,284$1.46M0.1%−40−1.2%ReducedHolders
Q1 20253,324$1.61M0.1%+334+11.2%AddedHolders
Q4 20242,990$1.20M<0.1%+2,000+202.0%AddedHolders
Q3 2024990$460.0K<0.1%+63+6.8%AddedHolders
Q2 2024927$435.0K<0.1%−106−10.3%ReducedHolders
Q1 20241,033$432.0K<0.1%00.0%UnchangedHolders
Q4 20231,033$420.0K<0.1%+29+2.9%AddedHolders
Q3 20231,004$349.0K<0.1%00.0%UnchangedHolders
Q2 20231,004$353.0K<0.1%00.0%UnchangedHolders
Q1 20231,004$316.0K<0.1%00.0%UnchangedHolders
Q4 20221,004$290.0K<0.1%00.0%UnchangedHolders
Q3 20221,004$291.0K<0.1%00.0%UnchangedHolders
Q2 20221,004$283.0K<0.1%−7−0.7%ReducedHolders
Q1 20221,011$264.0K<0.1%+4+0.4%AddedHolders
Q4 20211,007$221.0K<0.1%+1,007NewHolders
Q3 20210$00.0%−1,007−100.0%Sold outHolders
Q2 20211,007$203.0K<0.1%−193−16.1%ReducedHolders
Q1 20211,200$258.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.